home / stock / bbi / bbi news


BBI News and Press, Brickell Biotech Inc. From 01/18/22

Stock Information

Company Name: Brickell Biotech Inc.
Stock Symbol: BBI
Market: NYSE

Menu

BBI BBI Quote BBI Short BBI News BBI Articles BBI Message Board
Get BBI Alerts

News, Short Squeeze, Breakout and More Instantly...

BBI - Best High Volume Penny Stocks to Watch Right Now

3 High Volume Penny Stocks For Your January Watchlist While trading penny stocks and blue chips has gotten off to a rough start this week, many investors are optimistic about the future. With the Dow Jones Industrial Average down by more than 500 points and the S&P 500 down by aroun...

BBI - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! I hope you enjoyed the long weekend, but it’s time to get back into investing with the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com New agreements, FDA ...

BBI - Brickell Biotech, Inc. (BBI) CEO Rob Brown on Q3 2021 Results - Earnings Call Transcript

Brickell Biotech, Inc. (BBI) Q3 2021 Results Conference Call November 09, 2021 04:30 PM ET Company Participants Garth Russell - IR, LifeSci Advisors Rob Brown - CEO Bert Marchio - CFO Monica Luchi - Chief Medical Officer Deepak Chadha - Chief R&D Officer Andy Sklawer - COO Conference Call...

BBI - Brickell Biotech EPS misses by $0.03, misses on revenue

Brickell Biotech (NASDAQ:BBI): Q3 GAAP EPS of -$0.16 misses by $0.03. Revenue of $0.13M (-7.1% Y/Y) misses by $0.02M. Press Release For further details see: Brickell Biotech EPS misses by $0.03, misses on revenue

BBI - Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Announced positive topline results from the Phase 3 pivotal clinical studies of sofpironium bromide gel, 15% in primary axillary hyperhidrosis patients; plan to submit a New Drug Application (NDA) to the FDA in mid-2022 Development of DYRK1A inhibitors is ongoing, including a pl...

BBI - Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9, 2021

BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatolo...

BBI - Brickell Biotech falls 29% on pricing 26M stock offering

Brickell Biotech (NASDAQ:BBI) dropped 29% premarket after it priced its earlier announced underwritten public offering of 26.32M shares at $0.38/share. Underwriters granted 30-day option to purchase up to 3.95M shares. Offer is expected to close on Nov.1. Gross proceeds are exp...

BBI - Brickell Biotech Prices Public Offering of Common Stock

BOULDER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell”), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatolo...

BBI - Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock

BOULDER, Colo., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell”), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatolo...

BBI - Penny Stocks That Will Explode? 3 For Your Watchlist

3 Penny Stocks That Could Explode in November 2021 If you’re looking for penny stocks that could explode, there are hundreds of options to choose from. And while part of finding penny stocks to buy is looking at fundamentals, the main cause of movement tends to be speculation...

Previous 10 Next 10